Replies to post #133742 on Biotech Values

[zipjet]

Unless there are undisclosed terms in the MNTA-BAX partnership that impede a buyout of either company (possible but unlikely, IMO), a buyout of MNTA is not substantially more or less likely today than it was yesterday.

A buyout is less likely. Any company that wanted the MNTA tech/patents to apply to FoB's would be less likely or would pay less.

You don't need to see the deal terms to know that.

ij